Development and use of lipid nanoparticles containing edelfosine and other phospholipid ethers in antitumor therapy and antiparasitic

• 1. 包括具有含植物脂质的核心和含磷脂或极性脂质的脂质小球的营养组合物 [P] . 中国专利： CN102202526B . 2013.05.29
• 2. 包括具有含植物脂质的核心和含磷脂或极性脂质的脂质小球的营养组合物 [P] . 中国专利： CN102202526A . 2011-09-28
• 3. Development and use of lipid nanoparticles containing edelfosine ethers and other phospholipids in antitumor therapy and antiparasitic [P] . ES2388963A1 . 2012-10-22

  机译： 含依德福星醚和其他磷脂的脂质纳米颗粒在抗肿瘤治疗和抗寄生虫中的开发和应用

• 4. METHOD FOR PRODUCING COMPOSITION FOR PHOTODYNAMIC THERAPY IN FORM OF PHOSPHOLIPID NANOPARTICLES BASED ON GLUCAMINE CHLORINE E6 SALT, MALTOSE AND PHOSPHATIDYLCHOLINE [P] . 俄罗斯专利： RU2576025C1 . 2016-02-27

  机译： 基于谷氨酸氯E6盐，麦芽糖和磷脂酰胆碱的磷脂纳米颗粒形式的光动力疗法组合物的制备方法

• 5. METHOD FOR PREPARING PHOSPHOLIPID NANOPARTICLE ENCLOSED CHLORINE E6 COMPOSITION FOR PHOTODYNAMIC THERAPY [P] . 俄罗斯专利： RU2535054C1 . 2014-12-10

  机译： 用于光动力学治疗的磷脂纳米颗粒封闭氯E6组合物的制备方法

• 1. Long-Term Effects of Docosahexaenoic Acid-Bound Phospholipids and the Combination of Docosahexaenoic Acid-Bound Triglyceride and Egg Yolk Phospholipid on Lipid Metabolism in Mice [J] . CHE Hongxia, CUI Jie, WEN Min, 中国海洋大学学报（英文版） . 2018,第002期
• 2. Conformation and Orientation of Phospholipid Molecule in Pure Phospholipid Monolayer During Compressing [J] . XUE Weilan, WANG Dan, ZENG Zuoxiang, 中国化学工程学报（英文版） . 2013,第002期
• 3. Changes of Tumor Necrosis Factor, Surfactant Protein A, and Phospholipids in Bronchoalveolar Lavage Fluid in the Development and Progression of Coal Workers' Pneumoconiosis [J] . 生物医学与环境科学（英文版） . 2006,第002期
• 4. Development of NAMI-A-loaded PLGA-mPEG Nanoparticles: Physicochemical Characterization, in vitro Drug Release and in vivo Antitumor Efficacy [J] . YANG Yong-guang, LIU Du, XIA Yu, 高等学校化学研究（英文版） . 2011,第003期
• 5. Development of NAMI-A-loaded PLGA-mPEG Nanoparticles：Physicochemical Characterization, in vitro Drug Release and in vivo Antitumor Efficacy [J] . 无 高等学校化学研究：英文版 . 2011,第003期
• 6. Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria [J] . F Mollinedo, M Fernández, V Hornillos, Cell death & disease. . 2011,第5期
• 7. Quantitative determination of the antitumor alkyl ether phospholipid edelfosine by reversed-phase liquid chromatography-electrospray mass spectrometry: application to cell uptake studies and characterization of drug delivery systems [J] . Blanco-Prieto MJ, Campanero MA, Mollinedo F Journal of chromatography, B. Analytical technologies in the biomedical and life sciences . 2004,第1期
• 8. Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells [J] . Consuelo Gajate Faustino Mollinedo Current Drug Metabolism . 2002,第5期
• 9. Development of NiFe_2O_4/Au nanoparticles covered with lipid bilayers for applications in combined cancer therapy [C] . Ana Rita O. Rodrigues, Irina S. R. Rio, Elisabete M. S. Castanheira, International Conference on Applications of Optics and Photonics . 2019
• 10. Development of targeted phospholipid coated gamma-iron oxide nanoparticles as MR contrast agents [D] . Hultman, Kristi L. 2007
• 11. Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria [O] . F Mollinedo, M Fernández, V Hornillos, 2011
• 12. Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria [O] . Mollinedo, Faustino, Hornillos, Valentín, Delgado, Javier, 2011
• 13. Polymerized Phospholipid Membrane Mediated Synthesis of Metal Nanoparticles [R] . Singh, A., Chow, G., Markowitz, M. 1994

• 1. HPLC-ELSD法测定复合磷脂固醇脂质中磷脂酰胆碱的含量 [C] . 曾文珊 . 2006第六届中国药学会学术年会 . 2006
• 2. 脂质代谢、体重指数与乳腺癌发生相关性分析及三阴性乳腺癌经抗肿瘤治疗后血脂代谢变化 [A] . 黄赞 . 2019